Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478049
Status:
COMPLETED
Last Update Posted:
2012-06-06
First Post:
2007-05-23
Brief Title:
Iressa as Second Line Therapy in Advanced NSCLC-Asia
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Conditions & Keywords Data
Conditions:
| Name |
|---|
| NSCLC |
Keywords:
| Name | View |
|---|---|
| Non-Small Cell Lung Cancer | View |